A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]
Public ClinicalTrials.gov record NCT05565742. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3819469 in Adults With Elevated Lipoprotein(a)
Study identification
- NCT ID
- NCT05565742
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 320 participants
Conditions and interventions
Conditions
Interventions
- LY3819469 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 19, 2022
- Primary completion
- Oct 22, 2023
- Completion
- Oct 16, 2024
- Last update posted
- May 27, 2025
2022 – 2024
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Care Access - 801 South Power Road, Mesa | Mesa | Arizona | 85206 | — |
| Care Access - South Pasadena | Pasadena | California | 91105 | — |
| Care Access - Santa Clarita | Santa Clarita | California | 91321 | — |
| Care Access - Spring Hill | Spring Hill | Florida | 34609 | — |
| Care Access - Pebble Beach Boulevard, Tampa | Sun City | Florida | 33573 | — |
| Care Access - Tamarac | Tamarac | Florida | 33321 | — |
| Care Access - Tampa | Tampa | Florida | 33625 | — |
| Care Access - Lake Charles | Lake Charles | Louisiana | 70601 | — |
| Care Access - Baltimore | Baltimore | Maryland | 21213 | — |
| Care Access - Dorchester | Dorchester | Massachusetts | 02124 | — |
| Aventiv Research Inc | Columbus | Ohio | 43213 | — |
| Care Access - Lima | Lima | Ohio | 45805 | — |
| Capital Area Research, LLC | Camp Hill | Pennsylvania | 17011 | — |
| Lancaster General Hospital | Lancaster | Pennsylvania | 17602 | — |
| Cardiology Consultants of Philadelphia Yardley | Yardley | Pennsylvania | 19067 | — |
| Care Access - Rapid City | Rapid City | South Dakota | 57701 | — |
| Care Access - Georgetown | Georgetown | Texas | 78633 | — |
| Care Access - Katy | Katy | Texas | 77450 | — |
| Virginia Heart | Falls Church | Virginia | 22042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05565742, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05565742 live on ClinicalTrials.gov.